Sanjay Subramanian, SVP, CFO at Inozyme Pharma, Inc. (INZY), bought 27,100 shares at $3.69 ($100K) on 2022-04-19, disclosed to the SEC on 2022-04-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCGN | SELL | 2021-08-18 | $217K | — | Filing → |
| OCGN | SELL | 2021-07-16 | $417K | — | Filing → |
| OCGN | SELL | 2021-06-17 | $217K | — | Filing → |